Xeomin® in Manhattan, NYC
If you’re looking for a way to reduce moderate to severe wrinkles without the possibility that your body will eventually develop antibodies to a neurotoxin injection (similar to Botox®), Xeomin® injections, performed by board-certified Manhattan plastic surgeon and general surgeon Richard W. Swift, Jr., M.D., F.A.C.S., may be your answer.
What Is Xeomin®?
Xeomin® is a newer dermal injection that helps treat moderate to severe facial wrinkles including frown lines and lines between the brow. It is also used to treat hyperhidrosis (excessive underarm sweating) and MMH, a condition that results in a square, masculine-looking jaw in women due to an over-developed Masseter muscle.
Benefits of Xeomin®
Men and women who have had Xeomin® injections tell us that as a result, they feel the following benefits:
- Improved self-confidence and self-esteem
- Renewed vigor and youthful appearance
- More attractive, softer-looking skin
Xeomin® Before and After
We invite you to browse our extensive catalog of cosmetic treatments to see the types of results Dr. Swift has obtained for his patients. Keep in mind that each individual is different and that you’ll learn more about the outcome you can expect from your specific surgery or treatment at your consultation with Dr. Swift.
Preparing for Xeomin®
Because Xeomin® is an injectable, there is no specific preparation steps you’ll need to take before having your treatment done. Xeomin® treatments are often done during a lunch break, although it can take some time for the muscles to fully relax and facial muscles to smooth out, diminishing wrinkles as a result.
Xeomin® Recovery
Because no surgery is involved, no downtime is associated with Xeomin®. You can resume your normal activities and work right away, although you should not rub or massage the treatment area as this can cause Xeomin® to spread to other areas of the body where it may not be desired.
Is Xeomin® Right for Me?
If you have moderate to severe wrinkles, frown lines, or furrowed brow lines, Xeomin® may be an ideal choice for you. Dr. Swift can make a proper evaluation of your candidacy for Xeomin® treatment at our Manhattan facility, so contact our office today to learn more.
How Much Does Xeomin® Cost?
Costs for your Xeomin® treatment will vary depending on the number of treatments needed to achieve your desired result. Most insurance plans do not cover plastic surgery or specific cosmetic treatments. Dr. Swift accepts payment via cash, check, or credit card, as well as Prosper Healthcare Lending as a financing option.
Why Choose Dr. Swift?
Board-certified plastic surgeon Richard W. Swift, Jr., M.D., F.A.C.S. provides a variety of cosmetic surgeries and treatments to help improve and enhance your natural beauty. A graduate of Yale and Brown University, Dr. Swift has earned prestigious awards for his vast medical expertise and experience. In addition to offering a wide range of cosmetic surgery options, Dr. Swift can also provide detailed consultations on surgical techniques, alternative treatments, and pre- and post-operative care. Throughout the process, his number one goal is to deliver personalized, high-quality, one-on-one care to ensure your complete comfort and satisfaction.
What to Expect During Your Consultation?
Dr. Swift will evaluate the areas you wish to have treated with Xeomin® and discuss your treatment options while taking the time to answer all your questions. As Xeomin® is a relatively new injectable, it’s normal to have some concerns about its use. Dr. Swift will address these and explain how Xeomin® can help reduce the look of wrinkles in the face, as well as create a custom-crafted treatment plan just for you.
Enjoy softer, younger-looking skin – on your lunch break! Xeomin® is the new, FDA-approved treatment to help relax your facial muscles and give you a fresh new look right away. Contact our Manhattan, NYC office to schedule your consultation today.
XEOMIN® Before and After Photos at Maximum Frown
Individual results may vary. Unretouched photos. The highest proportion of patients achieved treatment success (at least 2 points improvement in both the investigator and patient ratings) at Day 30.
